On Sepember 1, 2017, Canada House Wellness Group Inc. (CSE:CHV) (OTC:SARSF) announced that its wholly-owned subsidiary, Abba Medix Inc., was approved by Health Canada to cultivate medical marijuana pursuant to the Access to Cannabis for Medical Purposes Regulations, a.k.a. ACMPR.
Related: Abba Medix Assigned Health Canada Reviewer
"We are very pleased to have received a license to cultivate cannabis under Canada's ACMPR," commented Company Director Riley McGee. "Our team understands that a license to cultivate is just the beginning of what's to come for Abba Medix, which looks to become a recognized producer of the highest quality of cannabis products within its Pickering, Ontario indoor grow facility."
Related: Canada House Wellness Acquires Knalysis
Canada House is also the parent company of Marijuana for Trauma and Knalysis Technologies. Canada House's goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated cannabis therapy company.
Related: 30+ Cannabis Companies in the CSE Composite Index
Be sure to subscribe to one or more of our free e-mail newsletters so you never miss an important marijuana stock update. Also, don't forget to connect with The Daily Marijuana Observer on social media via Facebook, Twitter, StockTwits, and Instagram.